Journal for ImmunoTherapy of Cancer (Nov 2021)
147 Memory phenotype in allogeneic anti-BCMA CAR-T cell therapy (P-BCMA-ALLO1) correlates with in vivo tumor control
- Yan Zhang,
- Elvira Argus,
- Maximilian Richter,
- Yening Tan,
- Min Tong,
- Eric Ostertag,
- Julia Coronella,
- Devon Shedlock,
- Jing Qiu,
- Stacey Cranert,
- Hubert Tseng,
- Karl Marquez,
- Benjamin Cho,
- Christine Domingo,
- Leslie Weiss,
- Jessica Sparks
Affiliations
- Yan Zhang
- Department of cardiology, Peking University First Hospital, Beijing, China
- Elvira Argus
- Poseida, San Diego, CA, USA
- Maximilian Richter
- Poseida, San Diego, CA, USA
- Yening Tan
- Poseida, San Diego, CA, USA
- Min Tong
- Poseida, San Diego, CA, USA
- Eric Ostertag
- Poseida, San Diego, CA, USA
- Julia Coronella
- Poseida, San Diego, CA, USA
- Devon Shedlock
- Poseida, San Diego, CA, USA
- Jing Qiu
- 2 Department of Human Resource, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China
- Stacey Cranert
- Poseida Therapeutics, Inc, San Diego, CA, USA
- Hubert Tseng
- Poseida Therapeutics, San Diego, CA, USA
- Karl Marquez
- Poseida Therapeutics, San Diego, CA, USA
- Benjamin Cho
- Poseida Therapeutics, San Diego, CA, USA
- Christine Domingo
- Poseida Therapeutics, San Diego, CA, USA
- Leslie Weiss
- Poseida Therapeutics, San Diego, CA, USA
- Jessica Sparks
- Poseida Therapeutics, San Diego, CA, USA
- DOI
- https://doi.org/10.1136/jitc-2021-SITC2021.147
- Journal volume & issue
-
Vol. 9,
no. Suppl 2
Abstract
No abstracts available.
